Human Granulocytic Anaplasmosis, Japan

We retrospectively confirmed 2 cases of human Anaplasma phagocytophilum infection. Patient blood samples contained unique p44/msp2 for the pathogen, and antibodies bound to A. phagocytophilum antigens propagated in THP-1 rather than HL60 cells. Unless both cell lines are used for serodiagnosis of rickettsiosis-like infections, cases of human granulocytic anaplasmosis could go undetected.

Case-patient 2, a 73-year-old lumberjack, sought medical care for fever (39.2°C), headache, and malaise (day 0, the day of symptom onset). On day 4, a disseminated maculopapular rash was noticed, especially on the trunk and lower limbs; JSF or scrub typhus infection was suspected. The patient was hospitalized and intravenously administered minocycline (200 mg/day). Results for laboratory tests (day 4) follow: leukocytes, 6.4 × 10 9 cells/L; aspartate aminotransferase, 100 U/L, alanine aminotransferase, 45 U/L; and C-reactive protein, 17.2 mg/dL.
In 2003, blood clots and serum samples from the 2 patients were transferred from Kochi Institute of Health to the University of Shizuoka, where they were stored at -20°C until a retrospective analysis could be performed. DNA was extracted from the blood clots, and nested PCR was performed, as described (3,9) rickettsia 16S rDNA was amplified from a sample from case-patient 2 ( Table 1). Amplicons of p44/msp2 were subjected to TA cloning (TA Cloning Kit; Life Technologies, Grand Island, NY, USA), and randomly selected recombinant clones were sequenced and analyzed phylogenetically ( Figure 1). A total of 28 p44/msp2 clones from case-patient 1 shared 27.5%-100% similarity with each other and were widely dispersed in the tree. The 40 clone sequences from case-patient 2 shared 97.5%-100% similarity with each other and grouped into a single cluster. Using Blast (http://blast.ncbi.nlm.nih. gov), we compared the sequences with those in GenBank; 27 previously identified p44/msp2 variants from human isolates and ticks collected in Japan were identified as the closest relatives to p44/msp2 cloned from the 2 patients. We included the 27 variants in the tree; however, some were widely separated from the related clones ( Figure 1). For case-patient 2, the 389-bp sequence of the 16S rDNA amplicon (determined by direct sequencing) was 100% identical to that of R. japonica YH (GenBank accession no. AP011533).
Serologic evidence of infection was demonstrated by using indirect immunofluorescence assay (IFA) and Western blot analysis as described (10,11). In IFAs, IgM and/ or IgG from serum samples from the case-patients reacted with A. phagocytophilum cultured in THP-1 rather than HL60 cells, and seroconversion was stronger in convalescent-phase serum samples (Table 2). IgG titers against R. japonica were also higher in convalescent-phase samples from case-patient 2. Western blot analysis further confirmed the specific reaction to the 44-kDa outer membrane proteins (P44s) of A. phagocytophilum cultured in THP-1 cells and/or to the recombinant P44-1 (rP44-1) in serum samples ( Figure 2, Table 2). However, using the same serum samples, we could not detect P44 antigens of A. phagocytophilum propagated in HL60 cells (data not shown), supporting the IFA result.
In central and western Japan, most cases of tickborne infectious and febrile disease have been reported as JSF (1,13), and R. japonica has been frequently detected in ixodid ticks in these areas. We found A. phagocytophilum infection in  A. phagocytophilum p44/msp2 was amplified by using primers p3726, p4257, p3761, and p4183, and Ehrlichia spp. p28/omp-1 was amplified by using primers conP28-F1, conP28-R1, conP28-F2, and conP28-R2, as described (3,9).  A. phagocytophilum cultured in HL60 cells is generally used as a source of antigen for serodiagnosis of human anaplasmosis. Our findings show, however, that titers of antibody against A. phagocytophilum propagated in THP-1 cells were higher than those propagated in HL60 cells. We further analyzed the transcription of p44/msp2 multigenes encoding P44 repertoires (major antigens of A. phagocytophilum) in infected HL60 and THP-1 cells by using reverse transcription PCR followed by TA cloning as described (7). The analyses showed that a transcript from the p44-60 gene and another from the p44-47 gene (75% and 25% of transcripts tested, respectively) were dominantly expressed in A. phagocytophilum propagated in THP-1 cells but not in HL60 cells; several transcript species other than p44-60 and p44-47 of p44/msp2 multigenes were expressed in A. phagocytophilum propagated in HL60 cells (data not shown). A previous proteomic study supported the variety of P44 repertoires produced by A. phagocytophilum in HL60 cells (14). The difference of p44/msp2 expression between HL60 and THP-1 cell cultures may reflect the discrepancy of antibody titers obtained by IFAs. Furthermore, in IFAs using infected THP-1 antigens, IgM titers tended to be higher than IgG titers, even in convalescent-phase serum samples. These patients probably produced IgG reactive with P44 species other than P44-60 and P44-47 that were dominantly expressed in A. phagocytophilum propagated in THP-1 cells; Western blot analysis showed that IgG in patients strongly bound to recombinant P44-1 rather than P44s (probably including P44-60 and P44-47) of A. phagocytophilum propagated in THP-1 cells. Thus, cases of hu-man anaplasmosis could go undiagnosed if only infected HL60 cells, and not THP-1 cells, are used as antigen for serodiagnosis of rickettsiosis-like infections, as is currently done when using IFAs.
To avoid misdiagnosing cases of human anaplasmosis, we recommend that A. phagocytophilum propagated in THP-1 and in HL60 cells be used as antigens for the serodiagnosis of rickettsiosis-like infections.
This work was supported in part by grants for Research on Emerging and Reemerging Infectious Diseases from the Association for Preventive Medicine of Japan and from the Japanese Ministry of Health, Labour and Welfare (H18-Shinkou -Ippan-014, H21-Shinkou-Ippan-006, and H24-Shinkou-Ippan-008); N.O. received a grant for the Global Center of Excellence Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Dr Ohashi is a professor in the Laboratory of Microbiology, Department of Food and Nutritional Sciences, School of Food and Nutritional Sciences, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Japan. His primary research interests are molecular biology, ecology, and epidemiology of zoonotic parasites, especially tickborne and foodborne pathogens.